Bolt Biotherapeutics
BOLT
BOLT
61 hedge funds and large institutions have $514M invested in Bolt Biotherapeutics in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
38% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 24
50% less capital invested
Capital invested by funds: $1.04B → $514M (-$523M)
Holders
61
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$11.1M | |
| 2 | +$8.89M | |
| 3 | +$8.25M | |
| 4 |
Morgan Stanley
New York
|
+$4.2M |
| 5 |
Goldman Sachs
New York
|
+$3.3M |
Top Sellers
| 1 | -$21.5M | |
| 2 | -$11.5M | |
| 3 | -$8.23M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$7.93M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$5.95M |